Answer
A validated one-stage clotting assay is recommended for measuring plasma factor VIII activity during ALTUVOCT (efanesoctocog alfa) treatment; an Actin-FSL-based one-stage assay was used throughout clinical development.
Sources for this answer
- ALTUVOCT 1 000 IU powder and solvent for solution for injectionSwedish Orphan Biovitrum Ltd · emc · SmPC §4.2 Posology and method of administration · Version 3Document updated
Sources checked